Montelukast Sodium
Product Images NDC 67296-1381

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 67296-1381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (18422beb 7f97 43aa 8f64 1d30aa8b07f7 907 2)

FDA Label Image

Figure 1 (57f07f65 1a14 4423 9da8 975664ca0684 01)

Change in height over time is being evaluated in centimeters for individuals taking Montelukast Sodium 5 mg and Boclomethasone 336 mog compared to placebo. The data is shown for weeks on treatment, with measurements at 0, 8, 16, 24, and 32 weeks.*

FDA Label Image

Structure (57f07f65 1a14 4423 9da8 975664ca0684 02)

FDA Label Image

Figure 2 (57f07f65 1a14 4423 9da8 975664ca0684 03)

Not available.*

FDA Label Image

Montelukast Sodium Tablets Usp, 10 mg-30t (57f07f65 1a14 4423 9da8 975664ca0684 04)

FDA Label Image

Montelukast Sodium Chewable Tablets Usp, 5 mg-30t (57f07f65 1a14 4423 9da8 975664ca0684 05)

This text describes a medication containing Montelukast Sodium 5 mg in chewable tablet form. It is recommended for pediatric patients aged 6-14 years and should be stored at room temperature, protected from moisture and light. The medication label also includes important information for pharmacists and patients. It is manufactured in Goa, India, and distributed by UNICHEM PHARMACEUTICALS in the USA.*

FDA Label Image

Montelukast Sodium Chewable Tablets Usp, 4 mg-30t (57f07f65 1a14 4423 9da8 975664ca0684 06)

This text provides information about a medication with the NDC code 29300-22, which is in the form of chewable tablets containing Montelukast Sodium. It includes storage instructions, details for pediatric patients aged 2-5 years, a warning for Phenylketonurics due to containing phenylalanine, and instructions for pharmacists to dispense the Medication Guide to each patient. The product is manufactured by UNICHEM LABORATORIES LTD in Goa, India, and is intended for distribution by UNICHEM PHARMACEUTICALS (USA), INC. in East Brunswick, New Jersey.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.